- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- ageddiagnostics.com
- Last Round
- Pre-SeedAug 2025
- Rounds
- 1
About
AGED (Active Genomes Expressed) Diagnostics is developing accurate, non-invasive blood tests for the early detection and staging of liver disease. Its genomics-based assays detect circulating genetic signatures associated with conditions such as fibrosis and steatohepatitis (NASH) and liver cancer, aiming to give clinicians an earlier, more affordable alternative to biopsy and current screening methods so patients can access intervention sooner.
Summary
AGED Diagnostics is a Medtech company based in San Francisco, United States, founded in 2022. Its most recent funding was a Pre-Seed round in Aug 2025. Investors include TEDCO, Plug and Play and Central Texas Angel Network.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2025
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.